PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 112 filers reported holding PULMONX CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $458,383 | -1.2% | 44,374 | +25.4% | 0.00% | – |
| Q2 2023 | $464,016 | +31.9% | 35,394 | +12.4% | 0.00% | – |
| Q1 2023 | $351,924 | +51.2% | 31,478 | +14.0% | 0.00% | – |
| Q4 2022 | $232,785 | -34.6% | 27,614 | +29.1% | 0.00% | – |
| Q3 2022 | $356,000 | +41.3% | 21,385 | +24.9% | 0.00% | – |
| Q2 2022 | $252,000 | -35.4% | 17,122 | +9.2% | 0.00% | – |
| Q1 2022 | $390,000 | -5.6% | 15,677 | +21.5% | 0.00% | – |
| Q4 2021 | $413,000 | -78.1% | 12,906 | -75.4% | 0.00% | -100.0% |
| Q3 2021 | $1,885,000 | +289.5% | 52,378 | +378.1% | 0.00% | – |
| Q2 2021 | $484,000 | +111.4% | 10,955 | +230.5% | 0.00% | – |
| Q4 2020 | $229,000 | – | 3,315 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |